Drug Type Small molecule drug |
Synonyms Compound 31(The University of Tennessee Health Science Center) |
Target |
Mechanism IL-33R inhibitors(Interleukin-1 receptor-like 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mastocytosis | Discovery | US | 18 Oct 2024 |